One blood draw, many cancers: new AI model aims to revolutionize screening
NCT ID NCT07554157
First seen May 09, 2026 · Last updated Jun 13, 2026 · Updated 8 times
Summary
This study aims to create a new way to screen for many types of cancer using just a routine blood test. Researchers will analyze data from 10 million people to train a computer model that can spot signs of cancer. The goal is to develop a low-cost, non-invasive tool that could be used for large-scale cancer screening.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.